Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH)
NCT05567666 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-08-19
Summary
A post-marketing study using Optilume Catheter System for benign prostatic hyperplasia.
Conditions
- Benign Prostatic Hyperplasia
Interventions
- DEVICE
-
Optilume Catheter System
Optilume Catheter System, which is a Dilation Drug Coated Balloon (DCB) Catheter
Sponsors & Collaborators
-
Urotronic Inc.
collaborator INDUSTRY -
Dean Elterman
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-07
- Primary Completion
- 2025-09-05
- Completion
- 2025-09-05
- FDA Device
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT00918034 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System
NCT06965582 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT00709488 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NCT05757687 ·Status: RECRUITING ·Phase: NA
-
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)
NCT02676544 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The ProVerum First in Man PROVE Study
NCT03972371 ·Status: COMPLETED ·Phase: NA
-
A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
NCT00465101 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH
NCT04245566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
NCT04627701 ·Status: RECRUITING ·Phase: NA
-
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
NCT00670306 ·Status: COMPLETED ·Phase: PHASE3
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)
NCT05330520 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
NCT03179670 ·Status: COMPLETED
-
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS
NCT01589263 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound-Guided Photoselective Vaporization of the Prostate
NCT02346500 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
RT-310 Dose Escalation BPH Study
NCT06136819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
NCT00449150 ·Status: TERMINATED ·Phase: PHASE3
-
Butterfly Pivotal Study
NCT05341661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years
NCT02757963 ·Status: COMPLETED ·Phase: PHASE4
-
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
NCT01876706 ·Status: COMPLETED ·Phase: NA
-
Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
NCT02019030 ·Status: TERMINATED
-
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
NCT01939184 ·Status: COMPLETED ·Phase: PHASE2